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Uterine artery embolisation (UAE) is an organ-
conserving, established, safe and effective proce-
dure in the physicianʼs toolbox for treating com-
plaints due to myoma.
The aim of UAE is rather to reduce or eliminate
complaints due to a myoma and not to remove
the myoma. At the same time a reduction of the
size of the myoma can be achieved.
There is agreement between the specialties gy-
naecology and interventional radiology that an
indication for the required therapy in cases of
uterus myomatosus is only given after expert ex-
amination by and consultation with a gynaecolo-
gist. A complete and comprehensive consultation
on treatment options for symptomatic uterus my-
omatosus explicitly includes, besides the drug
and surgical treatment options, also UAE. The de-
cision for or against a therapeutic option should
be made in consideration of the individual pa-
tientʼs wishes and with a full knowledge of other
strategies, their chances of success, their limita-
tions as well as their typical side effects and pos-
sible complications (informed consent).
In Germany, Austria and Switzerland, uterine ar-
tery embolisation provides a treatment option
for complaints due to myomas that enables a fur-
ther individualisation of the therapy for uterus
myomatosus.Aim of the Consensus Meeting
!
The intention of the consensus meeting was to
make an up-to-date evaluation of UAE. The par-
ticipants of the radiology-gynaecology expert
meeting have, on the basis of a renewed assess-
ment of the available literature, published inter-
national guidelines as well as their own experi-
ence and extensive discussions, reached a con-
sensus between the two involved specialties. TheKröncke T et al. Uterine Artgroup of experts was fully aware that the possibil-
ities and limitations of a radiological therapy op-
tion would have to be discussed with experts
from the field of gynaecology who do not perform
such procedures themselves but who have exten-
sive experience in the diagnosis and treatment of
diseases of the female genital organs.
The expert group comprising 14 radiologists and
8 gynaecologists that came together on January
19, 2013 in Berlin for the 4th radiology–gynaecol-
ogy consensus also included radiologists and gy-
naecologists from Switzerland and Austria. After
extensive and, in part, controversial discussion
the group formulated in consensus the following
recommendations. The consensus paper was sup-
ported by the gynaecologists and radiologists
listed at the end of the present contribution. This
paper reflects the current state of knowledge.Structural Prerequisites and Quality
Assurance in the Performance of UAE
!
UAE should only be carried out in hospitals in
which specialists in the fields of gynaecology and
radiology are present who have the necessary ex-
perience in its performance, where an adequate
and structured pain therapy after the operation
and expertise in the management of side effects
as well as of conservative and surgical therapy
for myoma are available.
In particular, due to the postoperative necessity
for pain therapy UAE should only be performed
in hospitals on an inpatient basis.
Prior to introduction of UAE in a hospital, theoret-
ical and practical training in a centre with exten-
sive experience in the performance of UAE as well
as participation in courses on the theory and
practice of UAE are strongly recommended. Be-
side the legally required documentation, for qual-
ity assurance the determined characteristic num-
bers for radiation exposure (dose area product,ery Embolisation… Geburtsh Frauenheilk 2014; 74: 433–435
434 GebFra Scienceexposure time) should also be checked every threemonths under
consideration of the average values given for UAE in the litera-
ture.
Participation in a suitable quality assurance programme of the
professional societies is also recommended.Examinations Necessary Prior to UAE
!
Fundamental for therapeutic decision making is a gynaecological
examination including vaginal and/or abdominal ultrasound (de-
pending on the size of the uterus myomatosus) by a specialist. If
the ultrasound diagnostics do not provide an unambiguous result
then there is a generous indication for an MRI study.
Prior to the embolisation of any myoma, the indications for hys-
teroscopy and fractionated abrasion should be checked. Also in
the past year at the most there should have been an unremark-
able cytological smear test of the cervix uteri.
Besides a test for pregnancy, the following laboratory results
must be available: creatinine, coagulation status, thyroid values
(in cases with positive thyroid history), blood count and CRP. An
active inflammation must be excluded by case history and clini-
cally.Indications for UAE
!
Indication for a uterine artery embolisation is a symptomatic
uterus myomatosus. UAE represents an alternative to surgical
and drug procedures as well as to myoma treatment with fo-
cussed ultrasound that is independent of the size and number of
myomas or previous operations. Foundations for the therapeutic
decision making are the objective of the treatment and the indi-
vidual patientʼs wishes.Criteria for Success of UAE
!
The main issues for therapeutic success after UAE are an im-
provement or complete elimination of the complaints (due to
myoma) stated by the patient and to a lesser extent a reduction
in volume of the dominating myoma or, respectively, the entire




" Prior treatment with GnRH analogues in the preceding 3
months (increased risk of vasospasm of the uterine artery)
Anatomic
Relative
" Isolated, submucosal myomas of types 0 and I according to
ESGE, that are suitable for hysteroscopic removal
" Isolated subserosal pedunculated myomas
" (Co-)supply of the myoma(s) via an ovarian artery; here the
benefits and risks of an additive embolisation of the respective
ovarian artery must be consideredKröncke T et al. Uterine Artery Embolisation… Geburtsh Frauenheilk 2014; 74: 433Clinical
Absolute
" Suspicion of malignancy
" Pregnancy
" Acute genital infection
" Manifest hyperthyroidism/active thyroiditis with hyperthy-
roid metabolic condition as well as planned or on-going radio-
iodine therapy, or when iodine-containing contrast media are
being used
Relative
" Documented allergic reaction to iodine-containing contrast
media
" Postmenopausal patients
" Allergic to local anaesthetics
" Latent hyperthyroidism
" Renal insufficiency (creatinine value > 1.5)
" Indwelling IUD
" Family planning not yet completed
" ImmunosuppressionUAE in Patients with a Desire to Have Children
!
When the wish to have children is not yet fulfilled UAE must be
considered as a last resort treatment. Possible risks include above
all a potential reduction of the ovarian reserves, an increased risk
of abortions, placentation disorders and heavier postnatal bleed-
ing.
For patients with an unfulfilled desire for children and a sympto-
matic uterus myomatosus, the role of UAE as treatment option
has not been sufficiently clarified in the available literature.
Before hysterectomy is considered for a patient with fulfilled
family planning and a pronounced uterus myomatosus the possi-
bility of a UAE should be taken into account.The Special Case of Preoperative Myoma Embolisation
(PUAE)
!
PUAE, i.e., embolisation as a direct preparation for surgical myo-
ma enucleation, can be considered and offered to individual pa-
tients who have a strong wish to retain their uterus and for
whom even preoperatively an elevated bleeding risk can be as-
sumed and/or for whom the risk of an eventually necessary hys-
terectomy is considered to be high for “technical reasons” (e.g.,
very large myoma and/or multiple myomas, myomas that would
be difficult to remove and myomas in unfavourable positions).
Radiation Protection
Radiation protection in UAE is especially important. If at all possi-
ble pulsed fluoroscopy should be employed. Serial angiographies
and oblique projections should be reduced to a minimum. As a
rule an acquisition frequency of 1 image/s is sufficient. The aver-
age value for the dose area product under normal conditions
should be less than 50Gy × cm2 for pulsed systems. The average
exposure time for UAE should amount to less than 20min. The
exposure to radiation here corresponds to that of about 2 to 3 CT
scans of the abdomen.–435





Angiography-related complications (e.g., inguinal haematoma) 2.9




Deep vein thrombosis/pulmonary embolus 0.2
435StatementSide Effects (l" Table 1)
!
Uterine discharges in the first weeks after UAE can be normal. In
the case of conspicuous vaginal discharges diagnosis of and ther-
apy for infections should be carried out. Menorrhagias, cramping
pain in the lower abdomen or discharge of tissue particles can oc-
cur, especially with submucosally displaced myomas. Depending
on the clinical symptomatics and the findings of imaging diag-
nostics a hysteroscopic myoma resection or a vaginal myoma
ablation as for a myoma in statu nascendi may be indicated. Hys-
terectomy is a priori not indicated. In cases of doubt the centre
that performed the UAE should be consulted.Follow-Up Examination after UAE
!
A follow-up examination by a specialist is recommended at about
6months after UAE. Imaging procedures (e.g., ultrasound in com-
bination with Doppler ultrasound, MRI) are helpful. In the ab-
sence of therapeutic success (no improvement of symptoms
and/or growth progression of the myoma) or conspicuous imag-
ing findings (increase in size of the myoma[s] or uterus and/or
lack of devascularisation of the myoma[s]) further clarification is
necessary.Perspectives
!
It is planned in 2015 under consideration of the data that will
then available and the gained experience to again reconsider
and revise these recommendations on uterine artery embolisa-
tion for complaints caused by myomas.Participants of the Consensus Meeting
!
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AGE, Arbeitsgemeinschaft Gynäkologische Endoskopie
DeGIR, Deutsche Gesellschaft für Interventionelle Radiologie
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